IGF2BP2 and hepatocellular carcinoma: Moreover, autoantibodies to IGF2BP2 were detected in the serum of some hepatocellular carcinoma patients but not in precancerous lesions like chronic hepatitis or liver cirrhosis hepatitis [96].